Evidence map›Paper›PMID 28742076›Full record

ArticleTranslational psychiatry2017

Altered neurite morphology and cholinergic function of induced pluripotent stem cell-derived neurons from a patient with Kleefstra syndrome and autism.

J Nagy, J Kobolák, S Berzsenyi, Z Ábrahám, H X Avci, I Bock, Z Bekes, B Hodoscsek, A Chandrasekaran, A Téglási and 11 more

Open access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Arrhythmias including atrial fibrillation and congenital heart disease in Kleefstra syndrome: a possible epigenetic link.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 2 institutions in 1 country.

J NagyPharmacology and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.
J KobolákBioTalentum Ltd., Gödöllő, Hungary.
S BerzsenyiPharmacology and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.
Z ÁbrahámPharmacology and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.
H X AvciBioTalentum Ltd., Gödöllő, Hungary.
I BockBioTalentum Ltd., Gödöllő, Hungary.ORCID http://orcid.org/0000-0001-9178-4506
Z BekesPharmacology and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.
B HodoscsekPharmacology and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.
A ChandrasekaranBioTalentum Ltd., Gödöllő, Hungary.
A TéglásiBioTalentum Ltd., Gödöllő, Hungary.
P DezsőPharmacology and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.
B KoványiPharmacology and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.
E T VörösPharmacology and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.
L FodorPharmacology and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.
T SzélPharmacology and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.
K NémethAutism Foundation, Budapest, Hungary.
A BalázsAutism Foundation, Budapest, Hungary.
A DinnyésBioTalentum Ltd., Gödöllő, Hungary.
B LendvaiPharmacology and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.
G LévayPharmacology and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.
V RománPharmacology and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.
Gedeon Richter (Hungary) · HUBioTalentum (Hungary) · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present study was to establish an in vitro Kleefstra syndrome (KS) disease model using the human induced pluripotent stem cell (hiPSC) technology. Previously, an autism spectrum disorder (ASD) patient with Kleefstra syndrome (KS-ASD) carrying a deleterious premature termination codon mutation in the EHMT1 gene was identified. Patient specific hiPSCs generated from peripheral blood mononuclear cells of the KS-ASD patient were differentiated into post-mitotic cortical neurons. Lower levels of EHMT1 mRNA as well as protein expression were confirmed in these cells. Morphological analysis on neuronal cells differentiated from the KS-ASD patient-derived hiPSC clones showed significantly shorter neurites and reduced arborization compared to cells generated from healthy controls. Moreover, density of dendritic protrusions of neuronal cells derived from KS-ASD hiPSCs was lower than that of control cells. Synaptic connections and spontaneous neuronal activity measured by live cell calcium imaging could be detected after 5 weeks of differentiation, when KS-ASD cells exhibited higher sensitivity of calcium responses to acetylcholine stimulation indicating a lower nicotinic cholinergic tone at baseline condition in KS-ASD cells. In addition, gene expression profiling of differentiated neuronal cells from the KS-ASD patient revealed higher expression of proliferation-related genes and lower mRNA levels of genes involved in neuronal maturation and migration. Our data demonstrate anomalous neuronal morphology, functional activity and gene expression in KS-ASD patient-specific hiPSC-derived neuronal cultures, which offers an in vitro system that contributes to a better understanding of KS and potentially other neurodevelopmental disorders including ASD.

Indexed as

AcetylcholineAutism Spectrum DisorderCalcium SignalingCell DifferentiationCells, CulturedChildChromosome DeletionChromosomes, Human, Pair 9Craniofacial AbnormalitiesFemaleGene ExpressionHeart Defects, CongenitalHistone-Lysine N-MethyltransferaseHumansIntellectual DisabilityMaleAcetylcholineEHMT1 protein, humanHistone-Lysine N-MethyltransferaseRNA, Messenger

Identifiers

PMID28742076
PMCPMC5538124
OpenAlexW2737153941

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.